Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02398708 · ClinicalTrials.gov registry record

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

A clinical trial of Graft-Versus-Host Disease and Graft Vs Host Disease, sponsored by University of Florida.

Completed
Registry status
38
Enrollment target
1
Study location

NCT02398708 is a study of Graft-Versus-Host Disease and Graft Vs Host Disease that has completed, run by University of Florida. The registered enrollment target is 38 participants, below the 82-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02398708, a study of Graft-Versus-Host Disease and Graft Vs Host Disease, has completed, sponsored by University of Florida.

COMPLETED
Registry status
38 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the gut bacteria, levels of peripheral blood inflammation markers, and symptoms in patients with and without chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplant (allo-HSCT). The hypothesis is that individuals with cGVHD will have lower levels of microbial diversity, higher levels of inflammatory metabolites in stool and peripheral measures, and higher levels of symptoms than individuals without cGVHD.

Conditions Studied

Graft-Versus-Host Disease Graft Vs Host Disease Hematopoietic Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation

Interventions

  • OTHER Questionnaires
  • OTHER Blood Sample
  • OTHER Stool Sample
  • OTHER Clinical data

Study Locations (1)

Florida

  • UF Health Cancer Hospital - Gainesville

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2015-05
Est. Completion 2016-04

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02398708

The ClinicalTrials.gov registry entry for NCT02398708 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (54% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Graft-Versus-Host Disease appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.

NCT02398708 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02398708 about?

NCT02398708 is a clinical study titled "Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT". The purpose of this study is to examine the gut bacteria, levels of peripheral blood inflammation markers, and symptoms in patients with and without chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplant (allo-HSCT). The hypothesis is that individuals with ...

What is the current status of trial NCT02398708?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2015-05. Estimated completion is 2016-04.

What conditions does trial NCT02398708 study?

This clinical trial studies the following conditions: Graft-Versus-Host Disease, Graft Vs Host Disease, Hematopoietic Stem Cell Transplantation, Peripheral Blood Stem Cell Transplantation.

What interventions are being tested in trial NCT02398708?

The interventions under investigation include: Questionnaires (OTHER), Blood Sample (OTHER), Stool Sample (OTHER), Clinical data (OTHER).

Who is sponsoring clinical trial NCT02398708?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02398708 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Graft-Versus-Host Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Graft-Versus-Host Disease

All registered trials for this condition

Graft Vs Host Disease

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.